OncoThera
OncoThera has developed a new treatment for Glioblastoma that can provide significantly better outcomes for patients who suffer from this deadly disease. With more than 22,000 diagnoses each year and a 5-year survival rate ranging from 5% to 19% depending on age, patients and physicians are looking for better treatment solutions. OncoThera’s patented treatment will soon be ready to enter human clinical trials and begin helping people with Glioblastoma.
- ewahl@neworleansbio.com
- 0 Comments
Submit a comment * Email address not published. Required fields marked with *